Technical Analysis for ACHN - Achillion Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 2.93 -6.39% -0.20
ACHN closed down 6.39 percent on Friday, March 22, 2019, on 89 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical ACHN trend table...

Date Alert Name Type % Chg
Mar 22 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 21 1,2,3 Pullback Bullish Bullish Swing Setup -6.39%
Mar 21 180 Bullish Setup Bullish Swing Setup -6.39%
Mar 21 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -6.39%
Mar 21 Wide Bands Range Expansion -6.39%
Mar 21 Overbought Stochastic Strength -6.39%
Mar 20 Bearish Engulfing Bearish -2.01%
Mar 20 Outside Day Range Expansion -2.01%
Mar 20 Wide Bands Range Expansion -2.01%

Older signals for ACHN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection. The company's drug candidates for treating chronic HCV infection comprise Sovaprevir, a NS3 protease inhibitor, which has completed a Phase IIa clinical trial; ACH-3102, a NS5A inhibitor that is in Phase IIa clinical trial; and ACH-2684, a NS3 protease inhibitor, which has completed Phase Ia and 1b clinical trials. Its pipeline of antibacterial product candidates includes ACH-702 for the treatment of dermatologic and ophthalmic infections; and ACH-2881 for the treatment of serious resistant bacterial infections, including methicillin-resistant staphylococcus aureus. The company was founded in 1998 and is headquartered in New Haven, Connecticut.
Chemistry Biopharmaceutical Chemical Compounds Organic Compounds Infection Antiviral Drug Cyclopropanes Drug Therapies HCV Carbamates Hepatitis C Virus Ns3 Ns5a Protease Inhibitor Sulfonamides
Is ACHN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.985
52 Week Low 1.29
Average Volume 1,581,640
200-Day Moving Average 2.769
50-Day Moving Average 2.4778
20-Day Moving Average 2.822
10-Day Moving Average 3.009
Average True Range 0.1747
ADX 44.75
+DI 26.9136
-DI 6.4634
Chandelier Exit (Long, 3 ATRs ) 2.7759
Chandelier Exit (Short, 3 ATRs ) 2.8841
Upper Bollinger Band 3.2288
Lower Bollinger Band 2.4152
Percent B (%b) 0.63
BandWidth 28.830617
MACD Line 0.1743
MACD Signal Line 0.1713
MACD Histogram 0.0029
Fundamentals Value
Market Cap 400.71 Million
Num Shares 137 Million
EPS -0.50
Price-to-Earnings (P/E) Ratio -5.86
Price-to-Sales 33.83
Price-to-Book 1.40
PEG Ratio -0.32
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.28
Resistance 3 (R3) 3.31 3.24 3.22
Resistance 2 (R2) 3.24 3.15 3.22 3.20
Resistance 1 (R1) 3.08 3.09 3.05 3.05 3.18
Pivot Point 3.01 3.01 2.99 2.99 3.01
Support 1 (S1) 2.85 2.92 2.82 2.82 2.68
Support 2 (S2) 2.78 2.86 2.76 2.66
Support 3 (S3) 2.62 2.78 2.64
Support 4 (S4) 2.59